Adlens wins landmark case in Arizona

British variable focus eyewear manufacturer Adlens has won what it described as a landmark case in Arizona which will permit the sale of its products in the state without prescription.

The case against Adlens began when the Arizona State Board of Dispensing Opticians questioned whether the adjustable focus eyewear could be sold without a prescription. It argued that it was a violation of the state laws regarding ready-to-wear eyewear and a risk to the user and the public. In response, a team led by Adlens director of industry and regulatory affairs Dr Graeme MacKenzie, presented clinical trial data to demonstrate that its product could be used safely without a prescription.